Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
- PMID: 21078153
- PMCID: PMC3219988
- DOI: 10.1186/cc9327
Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
Abstract
Introduction: This prospective study investigated the predictive value of procalcitonin (PCT) for survival in 242 adult patients with severe sepsis and septic shock treated in intensive care.
Methods: PCT was analyzed from blood samples of all patients at baseline, and 155 patients 72 hours later.
Results: The median PCT serum concentration on day 0 was 5.0 ng/ml (interquartile range (IQR) 1.0 and 20.1 ng/ml) and 1.3 ng/ml (IQR 0.5 and 5.8 ng/ml) 72 hours later. Hospital mortality was 25.6% (62/242). Median PCT concentrations in patients with community-acquired infections were higher than with nosocomial infections (P = 0.001). Blood cultures were positive in 28.5% of patients (n = 69), and severe sepsis with positive blood cultures was associated with higher PCT levels than with negative cultures (P = < 0.001). Patients with septic shock had higher PCT concentrations than patients without (P = 0.02). PCT concentrations did not differ between hospital survivors and nonsurvivors (P = 0.64 and P = 0.99, respectively), but mortality was lower in patients whose PCT concentration decreased > 50% (by 72 hours) compared to those with a < 50% decrease (12.2% vs. 29.8%, P = 0.007).
Conclusions: PCT concentrations were higher in more severe forms of severe sepsis, but a substantial concentration decrease was more important for survival than absolute values.
Figures




Comment in
-
What procalcitonin brings to management of sepsis in the ICU.Crit Care. 2010;14(6):1007. doi: 10.1186/cc9330. Epub 2010 Dec 1. Crit Care. 2010. PMID: 21138601 Free PMC article. Review.
-
In critically ill patients the procalcitonin level can be misleading.Crit Care. 2011;15(2):422. doi: 10.1186/cc10132. Epub 2011 Apr 28. Crit Care. 2011. PMID: 21542896 Free PMC article. No abstract available.
References
-
- Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9. - DOI - PubMed
-
- Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 2007;11:R38. doi: 10.1186/cc5723. - DOI - PMC - PubMed
-
- Jacobs JW, Lund PK, Potts JT Jr, Bell NH, Habener JF. Procalcitonin is a glycoprotein. J Biol Chem. 1981;256:2803–2807. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical